Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-05 | New | $19,952,387 | Unknown | Debt Only | SEC link | |
| 2023-03-13 | New | $59,982,508 | $59,982,508 | Equity Only | 06b | SEC link |
| 2022-09-01 | New | $5,000,000 | $5,000,000 | Debt Only | 06b | SEC link |
| 2020-05-18 | New | $33,222,703 | $33,222,703 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jonathan Behr | Director |
| Jason Brown | Executive |
| Roel Bulthuis | Director |
| Hagen Cramer | Executive |
| Laia Crespo Martin | Director |
| Luc Dochez | Director |
| Daniel Elbaum | Executive |
| Jonathan Fleming | Director |
| Johannes Fruehauf | Director |
| Angela Genge | Executive |
| Michael Hutton | Director |
| Cillian King | Director |
| Kasper C.D. Roet | Director, Executive, Promoter |
| Amy Schulman | Director |
| Vikas Sharma | Executive |
| Chris Thomajan | Executive |
| Julio E. Vega | Executive |
| Shafique Virani | Executive |
| Anne Whitaker | Director |